Use of recombinant B-cell differentiation factor for augmenting antibody production and stimulating bone marrow proliferation
US5362489A · kind A · utility
4Cited by
4References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 4, 1992 |
| Grant date | Nov 8, 1994 |
| Priority date | — |
| Expiry date | May 4, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/75
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A purified human B-cell differentiation factor (BCDF) which does not have a natural signal peptide attached to the N-terminal thereof, DNA encoding the BCDF, transformed cells containing such DNA, a process for producing and obtaining the BCDF, compositions containing the BCDF and various therapeutic uses are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.